nach oben

Erschienen in:

31.05.2016 | Original Article

Prevalence and associates of psychological distress in haematological cancer survivors

verfasst von: Alix E. Hall, Rob W. Sanson-Fisher, Mariko L. Carey, Chris Paul, Anna Williamson, Ken Bradstock, H. Sharon Campbell

Erschienen in: Supportive Care in Cancer | Ausgabe 10/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To explore outcomes of psychological distress, including anxiety, depression and stress, amongst adult haematological cancer survivors, with a specific focus on potential differences between rural and urban survivors.

Methods

One thousand four hundred fourteen urban and rural survivors were recruited from five Australian population-based cancer registries and completed a self-report pen-and-paper survey on their well-being, including the Depression Anxiety and Stress Scale 21-item version.

Results

A quarter of survivors were identified as reporting above normal levels of anxiety and depression, respectively, and almost one fifth (17 %) reported above normal levels of stress. There were no statistically significant differences in the percentage of rural and urban survivors reporting above normal levels of anxiety, depression, or stress. Survivors who had experienced financial burden due to their cancer or were of middle age had higher odds of reporting multiple domains of psychological distress, compared to their counterparts.

Conclusions

Haematological cancer survivors diagnosed during middle age or who experience increased financial burden as a result of their diagnosis may require additional support and care with regards to psychological distress.

Carlson LE, Angen M, Cullum J, Goodey E, Koopmans J, Lamont L, Bultz BD (2004) High levels of untreated distress and fatigue in cancer patients. Br J Cancer 90(12):2297–2304PubMedPubMedCentral

Linden W, Vodermaier A, MacKenzie R, Greig D (2012) Anxiety and depression after cancer diagnosis: prevalence rates by cancer type, gender, and age. J Affect Disord 141(2):343–351CrossRefPubMed

Allart P, Soubeyran P, Cousson-Gélie F (2013) Are psychosocial factors associated with quality of life in patients with haematological cancer? A critical review of the literature. Psycho-Oncology 22(2):241–249PubMed

Ell K, Sanchez K, Vourlekis B, Lee PJ, Dwight-Johnson M, Lagomasino I, Russell C (2005) Depression, correlates of depression, and receipt of depression care among low-income women with breast or gynecologic cancer. J Clin Oncol 23(13):3052–3060CrossRefPubMedPubMedCentral

DiMatteo MR, Lepper HS, Croghan TW (2000) Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 160(14):2101–2107CrossRefPubMed

Molassiotis A, Wilson B, Blair S, Howe T, Cavet J (2011) Unmet supportive care needs, psychological well-being and quality of life in patients living with multiple myeloma and their partners. Psycho-Oncology 20(1):88–97CrossRefPubMed

Montgomery C, Pocock M, Titley K, Lloyd K (2003) Predicting psychological distress in patients with leukaemia and lymphoma. J Psychosom Res 54(4):289–292CrossRefPubMed

Sherman AC, Simonton S, Latif U, Plante TG, Anaissie EJ (2009) Changes in quality-of-life and psychosocial adjustment among multiple myeloma patients treated with high-dose melphalan and autologous stem cell transplantation. Biol Blood Marrow Transplant 15:12–20CrossRefPubMed

Hjermstad MJ, Knobel H, Brinch L, Fayers PM, Loge JH, Holte H, Kaasa S (2004) A prospective study of health-related quality of life, fatigue, anxiety and depression 3–5 years after stem cell transplantation. Bone Marrow Transplant 34:257–266CrossRefPubMed

10.

Tecchio C, Bonetto C, Bertani M, Cristofalo D, Lasalvia A, Nichele I, Bonani A, Andreini A, Benedetti F, Ruggeri M, Pizzolo G (2013) Predictors of anxiety and depression in hematopoietic stem cell transplant patients during protective isolation. Psycho-Oncology 22:1790–1797CrossRefPubMed

11.

Clinton-McHarg T, Carey M, Sanson-Fisher R, Tzelepis F, Bryant J, Williamson A (2014) Anxiety and depression among haematological cancer patients attending treatment centres: prevalence and predictors. J Affect Disord 165:176–181CrossRefPubMed

12.

Priscilla D, Hamidin A, Azhar MZ, Noorjan KON, Salmiah MS, Bahariah K (2011) Assessment of depression and anxiety in haematological cancer patients and their relationship with quality of life. East Asian Arch Psychiatr 21:108–114

13.

Santos FR, Kozasa EH, Maria de Lourdes LF, Colleoni GW, Leite JR (2006) Psychosocial adaptation and quality of life among Brazilian patients with different hematological malignancies. J Psychosom Res 60(5):505–511CrossRefPubMed

14.

McCorkle R, Cooke E (2013) Psychosocial aspects of hematologic disorders. In: Hoffman R, Benz EJ, Silberstein LE, Heslop HE, Weitz JI, Anastais J (eds) Hematology: basic principles and practice, 6th edn. Elsevier Inc., Philadelphia

15.

National Institute for Clinical Excellence (2003) Guidance on cancer services- improving outcomes in haematological cancers: the manual. NICE, London, UK

16.

Butow PN, Phillips F, Schweder J, White K, Underhill C, Goldstein D (2012) Psychosocial well-being and supportive care needs of cancer patients living in urban and rural/regional areas: a systematic review. Support Care Cancer 20(1):1–22CrossRefPubMed

17.

Weaver KE, Geiger AM, Lu L, Case LD (2013) Rural-urban disparities in health status among US cancer survivors. Cancer 119(5):1050–1057CrossRefPubMed

18.

Boyes AW, Girgis A, D’Este C, Zucca AC (2011) Flourishing or floundering? Prevalence and correlates of anxiety and depression among a population-based sample of adult cancer survivors 6 months after diagnosis. J Affect Disord 135(1):184–192CrossRefPubMed

19.

Schootman M, Homan S, Weaver KE, Jeffe DB, Yun SY (2013) The health and welfare of rural and urban cancer survivors in Missouri. Prev Chronic Dis 10:130052CrossRef

20.

Paul CL, Hall AE, Carey ML, Cameron EC, Clinton‐McHarg T (2013) Access to care and impacts of cancer on daily life: do they differ for metropolitan versus regional hematological cancer survivors? J Rural Health 29(s1):s43–50CrossRefPubMed

21.

Dauch S, Dolbeault S, Reich M (2013) Depression in cancer patients. Eur J Cancer Suppl 2:205–215CrossRef

22.

Traeger L, Greer JA, Fernandez-Robles C, Temel JS, Pirl WF (2012) Evidence-based treatment of anxiety in patients with cancer. J Clin Oncol 30(11):1197–1205CrossRefPubMed

23.

Feuerstein M (2007) Defining cancer survivorship. J Cancer Surviv 1:5–7CrossRefPubMed

24.

Twombly R (2004) What’s in a name: who is a cancer survivor? J Nat Cancer Inst 96(19):1414–1415CrossRefPubMed

25.

Australian Bureau of Statistics (2013) Australian Statistical Geography Standard (ASGS): volume 5—remoteness structure. ABS Catalogue No. 1270.0.55.005. ABS, Canberra

26.

Hall AE, Sanson-Fisher RW, Lynagh MC, Threlfall T, D’Este CA (2013) Format and readability of an enhanced invitation letter did not affect participation rates in a cancer registry-based study: a randomized controlled trial. J Clin Epidemiol 66(1):85–94CrossRefPubMed

27.

Hall A, D’Este C, Tzelepis F, Sanson-Fisher R, Lynagh M (2014) The Survivor Unmet Needs Survey (SUNS) for haematological cancer survivors: a cross-sectional study assessing the relevance and psychometric properties. BMC Health Serv Res 14(1):211–223CrossRefPubMedPubMedCentral

28.

Lynagh M, Clinton-McHarg T, Hall A, Sanson-Fisher R, Stevenson W, Tiley C, Bisquera A (2015) Are Australian clinicians monitoring medication adherence in hematological cancer survivors? Two cross-sectional studies. Exp Hematol Oncol 4(15)

29.

Lovibond SH, Lovibond PF (1995) Manual for the Depression Anxiety Stress Scales, 2nd edn. Psychology Foundation Monograph, Sydney

30.

Brown TA, Chorpita BF, Korotitsch W, Barlow DH (1997) Psychometric properties of the Depression Anxiety Stress Scales (DASS) in clinical samples. Behav Res Ther 35(1):79–89CrossRefPubMed

31.

Gloster AT, Rhoades HM, Novy D, Klotsche J, Senior A, Kunik M, Stanley MA (2008) Psychometric properties of the Depression Anxiety and Stress Scale-21 in older primary care patients. J Affect Disord 110(3):248–259CrossRefPubMedPubMedCentral

32.

School of Psychology University of New South Wales (2011) DASS FAQ (frequently asked questions). http://www2.psy.unsw.edu.au/Groups/Dass/DASSFAQ.htm. Accessed March 2013

33.

National Comprehensive Cancer Network (2013) NCCN clinical practice guidelines in oncology: distress management version 2.2103. NCCN,

34.

Walker J, Sawhney A, Hansen CH, Ahmed S, Martin S, Symeonides S, Murray G, Sharpe M (2014) Treatment of depression in adults with cancer: a systematic review of randomized controlled trials. Psychol Med 44:897–907CrossRefPubMed

35.

Goldstein D, Underhill C (2007) Regional cancer services in Australia: some evidence of improvement but a long way to go. Cancer Forum 2(31)

36.

McGrath P (2000) It’s horrendous-but really, what can you do? Preliminary findings on financial impact of relocation for specialist treatment. Aust Health Rev 23(3):94–103CrossRefPubMed

37.

McGrath P, Seguerra J (2000) The patient transit assistance scheme: a consumer’s perspective. Aust J Rural Health 8(4):232–238CrossRefPubMed

38.

Bleyer A (2005) The adolescent and young adult gap in cancer care and outcome. Curr Probl Pediatr Adolesc Health Care 35(5):182–217CrossRefPubMed

39.

McAdams DP, Olson BD (2010) Personality developing continuity and change over the life course. Annu Rev Psychol 61:517–542CrossRefPubMed

40.

Hammond CT, Beckjord EB, Arora NK, Bellizzi KM, Jeffery DD, Aziz NM (2008) Non-Hodgkin’s lymphoma survivors’ fertility and sexual function-related information needs. Fertil Steril 90(4):1256–1258CrossRefPubMed

41.

Smith T, Stein KD, Mehta CC, Kaw C, Kepner JL, Buskirk T, Baker F (2007) The rationale, design, and implementation of the American Cancer Society’s studies of cancer survivors. Cancer 109(1):1–12CrossRefPubMed

42.

Watson N, Wooden M (2009) Identifying factors affecting longitudinal survey response. In: Lynn P (ed) Methodology of longitudinal surveys. John Wiley & Sons Ltd, Chichester

43.

Australian Bureau of Statistics (2015) 3218.0 regional population growth, Australia population estimates by remoteness area, 2004 to 2014. ABS, Canberra

Titel: Prevalence and associates of psychological distress in haematological cancer survivors
verfasst von: Alix E. Hall
Rob W. Sanson-Fisher
Mariko L. Carey
Chris Paul
Anna Williamson
Ken Bradstock
H. Sharon Campbell
Publikationsdatum: 31.05.2016
Verlag: Springer Berlin Heidelberg
Erschienen in: Supportive Care in Cancer / Ausgabe 10/2016
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-016-3282-3

Neu im Fachgebiet Onkologie

24.04.2024 | DGIM 2024 | Nachrichten

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Prevalence and associates of psychological distress in haematological cancer survivors

Abstract

Purpose

Methods

Results

Conclusions

Neu im Fachgebiet Onkologie

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Update Onkologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 10/2016

Falls in older adults with cancer: a systematic review of prevalence, injurious falls, and impact on cancer treatment

Illness perceptions and coping predict post-traumatic stress in caregivers of patients with head and neck cancer

Burden and happiness in head and neck cancer carers: the role of supportive care needs

Exceptional patients and communication in cancer care—are we missing another survival factor?

Quality of life-related outcomes from a patient-tailored integrative medicine program: experience of Russian-speaking patients with cancer in Israel

Erratum: Erratum to: Effectiveness of tapentadol prolonged release for the management of painful mucositis in head and neck cancers during intensity modulated radiation therapy

Neu im Fachgebiet Onkologie

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Update Onkologie